Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Aug;80(2):341–347. doi: 10.1172/JCI113078

High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.

J R Patsch, S Prasad, A M Gotto Jr, W Patsch
PMCID: PMC442243  PMID: 3611351

Abstract

Lipoprotein lipase (LPL) activity in postheparin plasma of 38 normolipidemic volunteers was related to the magnitude of postprandial lipemia after a fat meal, to triglyceride content of high density lipoprotein2 (HDL2), to hepatic lipase (HL) activity, and to HDL2 levels. LPL activity correlated indirectly with lipemia, triglyceride content of HDL2, HL activity, and levels of HDL2 but not of HDL3. HL activity correlated directly with lipemia and indirectly with HDL2 levels. Triglyceride content of HDL2 correlated directly with lipemia and indirectly with HDL2 levels. In HDL2, abundance of apolipoprotein (apo) A-II and the apoA-I/apoA-II ratio varied widely. The latter correlated positively with LPL activity and HDL2 levels, and, inversely, with HL activity, lipemia, and triglyceride content of HDL2. The study suggests that HDL-cholesterol is not an independent parameter of lipid transport, but is strongly affected by triglyceride metabolism through lipolytic enzymes, as exemplified by postprandial lipemia that affect both composition and plasma levels of HDL2.

Full text

PDF
341

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. W., Nichols A. V., Pan S. S., Lindgren F. T. High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. Atherosclerosis. 1978 Feb;29(2):161–179. doi: 10.1016/0021-9150(78)90005-9. [DOI] [PubMed] [Google Scholar]
  2. Atmeh R. F., Shepherd J., Packard C. J. Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy. Biochim Biophys Acta. 1983 Apr 13;751(2):175–188. doi: 10.1016/0005-2760(83)90172-8. [DOI] [PubMed] [Google Scholar]
  3. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  4. Behr S. R., Patsch J. R., Forte T., Bensadoun A. Plasma lipoprotein changes resulting from immunologically blocked lipolysis. J Lipid Res. 1981 Mar;22(3):443–451. [PubMed] [Google Scholar]
  5. Bengtsson G., Olivecrona T. The hepatic heparin releasable lipase binds to high density lipoproteins. FEBS Lett. 1980 Oct 6;119(2):290–292. doi: 10.1016/0014-5793(80)80274-2. [DOI] [PubMed] [Google Scholar]
  6. Berg K., Borresen A. L. Serum-high-density-lipoprotein and atherosclerotic heart-disease. Lancet. 1976 Mar 6;1(7958):499–501. doi: 10.1016/s0140-6736(76)90291-9. [DOI] [PubMed] [Google Scholar]
  7. Blanche P. J., Gong E. L., Forte T. M., Nichols A. V. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta. 1981 Sep 24;665(3):408–419. doi: 10.1016/0005-2760(81)90253-8. [DOI] [PubMed] [Google Scholar]
  8. Cheung M. C., Albers J. J. Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. J Lipid Res. 1982 Jul;23(5):747–753. [PubMed] [Google Scholar]
  9. DE LALLA O. F., GOFMAN J. W. Ultracentrifugal analysis of serum lipoproteins. Methods Biochem Anal. 1954;1:459–478. doi: 10.1002/9780470110171.ch16. [DOI] [PubMed] [Google Scholar]
  10. Deckelbaum R. J., Granot E., Oschry Y., Rose L., Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis. 1984 May-Jun;4(3):225–231. doi: 10.1161/01.atv.4.3.225. [DOI] [PubMed] [Google Scholar]
  11. Demacker P. N., Stuyt P. M., Hijmans A. G., Van 't Laar A. Absence of inhibition of hepatic lipase by HDL. Atherosclerosis. 1983 Jul;48(1):101–103. doi: 10.1016/0021-9150(83)90021-7. [DOI] [PubMed] [Google Scholar]
  12. Goldberg R. B., Karlin J. B., Juhn D. J., Scanu A. M., Edelstein C., Rubenstein A. H. Characterization and measurement of human apolipoprotein A-II by radioimmunoassay. J Lipid Res. 1980 Sep;21(7):902–912. [PubMed] [Google Scholar]
  13. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  14. Huttunen J. K., Ehnholm C., Kinnunen P. K., Nikkilä E. A. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta. 1975 Sep 16;63(3):335–347. doi: 10.1016/0009-8981(75)90055-8. [DOI] [PubMed] [Google Scholar]
  15. Jensen G. L., Daggy B., Bensadoun A. Triacylglycerol lipase, monoacylglycerol lipase and phospholipase activities of highly purified rat hepatic lipase. Biochim Biophys Acta. 1982 Mar 12;710(3):464–470. doi: 10.1016/0005-2760(82)90130-8. [DOI] [PubMed] [Google Scholar]
  16. Karlin J. B., Juhn D. J., Scanu A. M., Rubenstein A. H. Measurement of serum apolipoprotein B by radioimmunoassay. Eur J Clin Invest. 1978 Feb;8(1):19–26. doi: 10.1111/j.1365-2362.1978.tb00803.x. [DOI] [PubMed] [Google Scholar]
  17. Karlin J. B., Juhn D. J., Starr J. I., Scanu A. M., Rubenstein A. H. Measurement of human high density lipoprotein apolipoprotein A-1 in serum by radioimmunoassay. J Lipid Res. 1976 Jan;17(1):30–37. [PubMed] [Google Scholar]
  18. Kinnunen P. K., Vainio P., Thurén T. Evidence against the role of hepatic endothelial lipase in the metabolism of plasma HDL2. Atherosclerosis. 1981 Nov-Dec;40(3-4):377–379. doi: 10.1016/0021-9150(81)90150-7. [DOI] [PubMed] [Google Scholar]
  19. Kuusi T., Nikkilä E. A., Taskinen M. R., Tikkanen M. J. Role of hepatic endothelial lipase in the metabolism of plasma HDL. Atherosclerosis. 1982 Aug;44(2):237–240. doi: 10.1016/0021-9150(82)90117-4. [DOI] [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. Maciejko J. J., Mao S. J. Radioimmunoassay of apolipoprotein A-i. application of a non-ionic detergent (Tween-20) and solid-phase staphylococcus. Clin Chem. 1982 Jan;28(1):199–204. [PubMed] [Google Scholar]
  22. Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
  23. Morton R. E., Zilversmit D. B. Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J Biol Chem. 1983 Oct 10;258(19):11751–11757. [PubMed] [Google Scholar]
  24. Nägele U., Hägele E. O., Sauer G., Wiedemann E., Lehmann P., Wahlefeld A. W., Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984 Feb;22(2):165–174. doi: 10.1515/cclm.1984.22.2.165. [DOI] [PubMed] [Google Scholar]
  25. Patsch J. R., Gotto A. M., Jr, Olivercrona T., Eisenberg S. Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4519–4523. doi: 10.1073/pnas.75.9.4519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Patsch J. R., Karlin J. B., Scott L. W., Smith L. C., Gotto A. M., Jr Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1449–1453. doi: 10.1073/pnas.80.5.1449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Patsch J. R., Prasad S., Gotto A. M., Jr, Bengtsson-Olivecrona G. Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. J Clin Invest. 1984 Dec;74(6):2017–2023. doi: 10.1172/JCI111624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Patsch J. R., Sailer S., Kostner G., Sandhofer F., Holasek A., Braunsteiner H. Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation. J Lipid Res. 1974 Jul;15(4):356–366. [PubMed] [Google Scholar]
  29. Patsch W., Sailer S., Braunsteiner H. An enzymatic method for the determination of the initial rate of cholesterol esterification in human plasma. J Lipid Res. 1976 Mar;17(2):182–185. [PubMed] [Google Scholar]
  30. Patsch W., Schonfeld G., Gotto A. M., Jr, Patsch J. R. Characterization of human high density lipoproteins by zonal ultracentrifugation. J Biol Chem. 1980 Apr 10;255(7):3178–3185. [PubMed] [Google Scholar]
  31. Rhoads G. G., Gulbrandsen C. L., Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med. 1976 Feb 5;294(6):293–298. doi: 10.1056/NEJM197602052940601. [DOI] [PubMed] [Google Scholar]
  32. Rothblat G. H., Bamberger M., Phillips M. C. Reverse cholesterol transport. Methods Enzymol. 1986;129:628–644. doi: 10.1016/0076-6879(86)29095-3. [DOI] [PubMed] [Google Scholar]
  33. Siedel J., Hägele E. O., Ziegenhorn J., Wahlefeld A. W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983 Jun;29(6):1075–1080. [PubMed] [Google Scholar]
  34. Tall A. R. Plasma lipid transfer proteins. J Lipid Res. 1986 Apr;27(4):361–367. [PubMed] [Google Scholar]
  35. Warnick G. R., Benderson J., Albers J. J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982 Jun;28(6):1379–1388. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES